Verity Asset Management
ABBV icon

Verity Asset Management’s AbbVie ABBV Stock Holding History

Verity Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$726K Buy
2,776
+69
+3% +$17.7K 0.28% 94
2026
Q2 		$681K Sell
2,707
-131
-5% -$28.2K 0.26% 105
2026
Q1 		$617K Buy
2,838
+20
+0.7% +$4.44K 0.26% 107
2025
Q4 		$644K Buy
2,818
+156
+6% +$35.5K 0.28% 103
2025
Q3 		$616K Sell
2,662
-2
-0.1% -$407 0.2% 113
2025
Q2 		$494K Buy
2,664
+305
+13% +$56.7K 0.24% 108
2025
Q1 		$494K Buy
2,359
+261
+12% +$50.7K 0.2% 115
2024
Q4 		$360K Buy
2,098
+344
+20% +$63.2K 0.2% 111
2024
Q3 		$347K Buy
1,754
+116
+7% +$21.6K 0.13% 141
2024
Q2 		$281K Buy
1,638
+148
+10% +$24.5K 0.11% 152
2024
Q1 		$271K Sell
1,490
-1
-0.1% -$172 0.15% 156
2023
Q4 		$231K Buy
+1,491
New +$217K 0.15% 161

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $483B AUM 27.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Verity Asset Management's ABBV Position: Q3 2026 in Review

Verity Asset Management increased its AbbVie (ABBV) stake by 2.5% in Q3 2026, buying an estimated $17.7K and bringing the position to 2,776 shares worth $726K. The position accounts for 0.28% of the portfolio, ranked #94.

Verity Asset Management first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 3,386 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Verity Asset Management held 2,776 shares of AbbVie worth $726K as of Q3 2026.
  • Verity Asset Management bought 69 AbbVie shares in Q3 2026, an estimated $17.7K.
  • AbbVie made up 0.28% of Verity Asset Management's portfolio in Q3 2026, its #94 holding.
  • Verity Asset Management first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 3,386 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Verity Asset Management's 13F filing for Q3 2026, filed 30 Oct 2026.